Fintel reports that on April 7, 2026, Citigroup downgraded their outlook for Bio-Rad Laboratories (NYSE:BIO) from Buy to Neutral. Analyst Price Forecast Suggests 22.54% Upside As of March 27, 2026, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Value Fund”. A copy of the letter can be downloaded here. The Fund seeks to ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies, with the ...

Rad Web Hosting’s fully-managed VPS hosting supports a wide range of applications—from eCommerce and SaaS to high-traffic websites and enterprise workloads. Today’s businesses need more than just ...

Bio-Rad Labs (BIO) has delivered a 26.23% change over the past year, with a 52-week range between 211.43 and 343.12. What Is the Average Daily Trading Volume of Bio-Rad Labs (BIO)? The average daily ...